Skip to Content

Workers’ Compensation Board

Search menu

We are working to fix a technical issue involving the Virtual Hearings iOS app. Affected users can still join their hearings from a web browser on their iOS device, or their laptop/desktop, by going to http://www.wcb.ny.gov/virtual-hearings/. Users may also attend their hearings using the Android VHC app.

Save the Date – COVID-19 and Workers’ Compensation Webinars

Language Access Policy  |  Disclaimer Regarding the Use of "Google Translate"

Subject Number 046-950 Temporary Suspension of Dr. Martin S. Tesher’s Authorization to Treat Injured Workers Effective June 9, 2017

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 170832-0W

June 12 2017

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. Martin S. Tesher’s authorization to treat injured workers within the New York State workers’ compensation system effective June 9, 2017. Dr. Tesher's last known business address is 9 East 68th Street, New York, New York 10065.

The Chair’s designee’s investigation has revealed that on or about June 5, 2017, Dr. Tesher was arrested by Brooklyn federal agents for allegedly writing more than 14,000 oxycodone prescriptions that allegedly generated 2.2 million oxycodone pills, which amounts to approximately $20 million worth of opioids.

Therefore, the Chair believes that Dr. Tesher may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Dr. Tesher is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Tesher for services rendered prior to June 9, 2017, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Tesher for services rendered prior to June 9, 2017, should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.

Kenneth J. Munnelly
Chair